Literature DB >> 20116332

Antimicrobial peptides: general overview and clinical implications in human health and disease.

Eduardo Guaní-Guerra1, Teresa Santos-Mendoza, Saúl O Lugo-Reyes, Luis M Terán.   

Abstract

Antimicrobial peptides (AMPs) are evolutionarily conserved molecules involved in the defense mechanisms of a wide range of organisms. Produced in bacteria, insects, plants and vertebrates, AMPs protect against a broad array of infectious agents. In mammals these peptides protect against bacteria, viruses, fungi, and certain parasites. Recently, novel biologic effects of AMPs have been documented such as endotoxin neutralization, chemotactic and immunomodulating activities, induction of angiogenesis and wound repair. Thus these ancestral molecules are crucial components of the innate immune system and attractive candidates for novel therapeutic approaches. This review focuses on cathelicin and defensins, the most documented human AMPs, and discusses their antimicrobial activity and pleiotropic immunomodulating effects on inflammatory and infectious diseases. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116332     DOI: 10.1016/j.clim.2009.12.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  135 in total

1.  Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.

Authors:  E N Lorenzón; G F Cespedes; E F Vicente; L G Nogueira; T M Bauab; M S Castro; E M Cilli
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 2.  Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.

Authors:  E Andrès
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-01       Impact factor: 3.267

Review 3.  Cationic host defence peptides: multifaceted role in immune modulation and inflammation.

Authors:  Ka-Yee Choi; Leola N Y Chow; Neeloffer Mookherjee
Journal:  J Innate Immun       Date:  2012-03-14       Impact factor: 7.349

4.  Natural product-derived quaternary ammonium compounds with potent antimicrobial activity.

Authors:  Maureen D Joyce; Megan C Jennings; Celina N Santiago; Madison H Fletcher; William M Wuest; Kevin Pc Minbiole
Journal:  J Antibiot (Tokyo)       Date:  2015-11-18       Impact factor: 2.649

Review 5.  The role of mucosal immunity and host genetics in defining intestinal commensal bacteria.

Authors:  Jonathan Hansen; Ajay Gulati; R Balfour Sartor
Journal:  Curr Opin Gastroenterol       Date:  2010-11       Impact factor: 3.287

6.  Determination of comparative minimum inhibitory concentration (MIC) of bacteriocins produced by enterococci for selected isolates of multi-antibiotic resistant Enterococcus spp.

Authors:  Maryam Hassan; Yousef Javadzadeh; Farzaneh Lotfipour; Rajabali Badomchi
Journal:  Adv Pharm Bull       Date:  2011-12-15

7.  Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria.

Authors:  Nathaniel P Chongsiriwatana; Modi Wetzler; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

8.  Investigating the effect of a single glycine to alanine substitution on interactions of antimicrobial peptide latarcin 2a with a lipid membrane.

Authors:  Grace Idiong; Amy Won; Annamaria Ruscito; Bonnie O Leung; Adam P Hitchcock; Anatoli Ianoul
Journal:  Eur Biophys J       Date:  2011-07-07       Impact factor: 1.733

9.  Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli.

Authors:  Xing-Jun Feng; Li-Wei Xing; Di Liu; Xue-Ying Song; Chun-Long Liu; Jing Li; Wen-Shan Xu; Zhong-Qiu Li
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-27       Impact factor: 3.346

Review 10.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.